Sri Sai Subramanyam Challa. “EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 28, no. 2, Aug. 2021, pp. 436-48, https://doi.org/10.53555/jptcp.v28i2.7421.